| Therapeutically exploiting STAT3 activity in cancer—using tissue repair as a road map J Huynh, A Chand, D Gough, M Ernst Nature Reviews Cancer 19 (2), 82-96, 2019 | 488 | 2019 |
| Inhibin: a candidate gene for premature ovarian failure AN Shelling, KA Burton, AL Chand, CC van Ee, JT France, CM Farquhar, ... Human Reproduction 15 (12), 2644-2649, 2000 | 272 | 2000 |
| Identification of novel mutations in FOXL2 associated with premature ovarian failure SE Harris, AL Chand, IM Winship, K Gersak, K Aittomäki, AN Shelling MHR: Basic science of reproductive medicine 8 (8), 729-733, 2002 | 261 | 2002 |
| Inhibin and premature ovarian failure AL Chand, CA Harrison, AN Shelling Human reproduction update 16 (1), 39-50, 2010 | 168 | 2010 |
| Emerging roles for IL-11 signaling in cancer development and progression: Focus on breast cancer CN Johnstone, A Chand, TL Putoczki, M Ernst Cytokine & growth factor reviews 26 (5), 489-498, 2015 | 138 | 2015 |
| Mutational analysis of BMP15 and GDF9 as candidate genes for premature ovarian failure AL Chand, AP Ponnampalam, SE Harris, IM Winship, AN Shelling Fertility and sterility 86 (4), 1009-1012, 2006 | 125 | 2006 |
| The orphan nuclear receptor LRH-1 promotes breast cancer motility and invasion AL Chand, KA Herridge, EW Thompson, CD Clyne Endocrine-related cancer 17 (4), 965, 2010 | 105 | 2010 |
| Repurposing of drugs as STAT3 inhibitors for cancer therapy PS Thilakasiri, RS Dmello, TL Nero, MW Parker, M Ernst, AL Chand Seminars in cancer biology 68, 31-46, 2021 | 89 | 2021 |
| The angiotensin receptor blocker, Losartan, inhibits mammary tumor development and progression to invasive carcinoma R Coulson, SH Liew, AA Connelly, NS Yee, S Deb, B Kumar, AC Vargas, ... Oncotarget 8 (12), 18640, 2017 | 88 | 2017 |
| ADAM17 is required for EGF-R–induced intestinal tumors via IL-6 trans-signaling S Schmidt, N Schumacher, J Schwarz, S Tangermann, L Kenner, ... Journal of Experimental Medicine 215 (4), 1205-1225, 2018 | 74 | 2018 |
| The orphan nuclear receptor LRH-1 and ERα activate GREB1 expression to induce breast cancer cell proliferation AL Chand, DD Wijayakumara, KC Knower, KA Herridge, TL Howard, ... PloS one 7 (2), e31593, 2012 | 74 | 2012 |
| Therapeutic potential of liver receptor homolog-1 modulators KA Lazarus, D Wijayakumara, AL Chand, ER Simpson, CD Clyne The Journal of steroid biochemistry and molecular biology 130 (3-5), 138-146, 2012 | 72 | 2012 |
| INHA promoter polymorphisms are associated with premature ovarian failure SE Harris, AL Chand, IM Winship, K Gersak, Y Nishi, T Yanase, H Nawata, ... Molecular human reproduction 11 (11), 779-784, 2005 | 72 | 2005 |
| Laser capture microdissection and cDNA array analysis of endometrium identify CCL16 and CCL21 as epithelial-derived inflammatory mediators associated with endometriosis AL Chand, AS Murray, RL Jones, NJ Hannan, LA Salamonsen, ... Reproductive Biology and Endocrinology 5, 1-13, 2007 | 62 | 2007 |
| Distinct nuclear receptor expression in stroma adjacent to breast tumors KC Knower, AL Chand, N Eriksson, K Takagi, Y Miki, H Sasano, ... Breast Cancer Research and Treatment 142, 211-223, 2013 | 59 | 2013 |
| STAT3 signaling in breast cancer: multicellular actions and therapeutic potential SQ To, RS Dmello, AK Richards, M Ernst, AL Chand Cancers 14 (2), 429, 2022 | 54 | 2022 |
| Evaluating the benefits of renin-angiotensin system inhibitors as cancer treatments MV Perini, RS Dmello, TL Nero, AL Chand Pharmacology & therapeutics 211, 107527, 2020 | 52 | 2020 |
| Aromatase expression is increased in BRCA1mutation carriers AL Chand, kConFab heather. thorne@ petermac. org, ER Simpson, ... BMC cancer 9, 1-9, 2009 | 52 | 2009 |
| Functional analysis of the human inhibin α subunit variant A257T and its potential role in premature ovarian failure AL Chand, GT Ooi, CA Harrison, AN Shelling, DM Robertson Human Reproduction 22 (12), 3241-3248, 2007 | 52 | 2007 |
| Repurposing the selective estrogen receptor modulator bazedoxifene to suppress gastrointestinal cancer growth P Thilakasiri, J Huynh, AR Poh, CW Tan, TL Nero, K Tran, AC Parslow, ... EMBO molecular medicine 11 (4), e9539, 2019 | 43 | 2019 |
Matthias ErnstProfessor | Head, School of Cancer Medicine, La Trobe Universityonjcri.org.au의 이메일 확인됨
